The biotechnology firm Prime Medicine is approaching what could be its most definitive period. Following its 2025 annual results, the company is shifting its strategic emphasis from initial clinical ...
Prime Medicine, Inc. ( (PRME)) has issued an update. On March 3, 2026, Prime Medicine reported full-year 2025 financial results and outlined progress across its Prime Editing pipeline, highlighting ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する